Edition:
United States

Alere Inc (ALR)

ALR on New York Consolidated

37.58USD
9 Dec 2016
Change (% chg)

$0.23 (+0.62%)
Prev Close
$37.35
Open
$37.50
Day's High
$37.99
Day's Low
$37.02
Volume
457,177
Avg. Vol
795,762
52-wk High
$54.13
52-wk Low
$31.47

ALR

Chart for ALR

About

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals... (more)

Overall

Beta: 0.61
Market Cap(Mil.): $3,269.56
Shares Outstanding(Mil.): 87.00
Dividend: --
Yield (%): --

Financials

  ALR Industry Sector
P/E (TTM): -- 57.76 30.40
EPS (TTM): -0.88 -- --
ROI: -1.74 7.10 15.24
ROE: -5.16 10.71 16.58

Abbott seeks to abort planned acquisition of Alere

Abbott Laboratories said on Wednesday that it had moved to terminate its proposed acquisition of Alere Inc , citing a "substantial loss" in the value of the diagnostics company since they struck a deal 10 months back.

Dec 07 2016

CMS revokes Alere unit's Medicare enrollment

Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

Nov 04 2016

CMS revokes Alere unit's Medicare enrollment

Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

Nov 04 2016

UPDATE 2-CMS revokes Alere unit's Medicare enrollment

Nov 4 Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

Nov 04 2016

REFILE-CMS to revoke Alere unit's Medicare enrollment

Nov 4 The Centers for Medicare and Medicaid Services (CMS) sent Alere Inc a notice on Oct. 5 saying it would revoke the Medicare enrollment of one of the molecular diagnostic company's unit, Alere said in a regulatory filing on Friday.

Nov 04 2016

BRIEF-Alere's unit Arriva Medical receives notice that medicare enrollment will be revoked by CMS

* Alere - on oct 12, co's unit arriva medical received notice, dated oct 5, that medicare enrollment will be revoked by CMS - sec filing

Nov 04 2016

BRIEF-Alere reports Q3 EPS $0.19 from continuing operations

* Q3 earnings per share view $0.54 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Nov 04 2016

CORRECTED-UPDATE 3-Abbott moves ahead on St. Jude, Alere deals, but investors fret

Oct 19 Abbott Laboratories said on Wednesday it was pushing ahead to complete its planned purchases of medical device maker St. Jude Medical Inc and diagnostics company Alere Inc despite lingering questions about product safety and government investigations.

Oct 20 2016

BRIEF-China clears Abbott's acquisition of Alere

* People's Republic of China clears Abbott acquisition of Alere

Oct 20 2016

Abbott moves ahead on St. Jude, Alere deals, but investors fret

Abbott Laboratories said on Wednesday it was pushing ahead to complete its planned purchases of medical device maker St. Jude Medical Inc and diagnostics company Alere Inc despite lingering questions about product safety and government investigations.

Oct 19 2016

Competitors

Earnings vs. Estimates